SCHEMBL4886947

SCHEMBL4886947

N#CCCOP(=O)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10698483 0.85 ALDH1A1 (0.33) —
SCHEMBL29285247 0.81 — —
SCHEMBL733409 0.79 ALDH1A1 (0.43) —
SCHEMBL29285237 0.77 — —
SCHEMBL28408950 0.76 ALDH1A1 (0.37) —
SCHEMBL413500 0.75 — —
SCHEMBL10935262 0.75 — —
Water SCHEMBL6908198 0.75 LPAR3 (0.41) —
SCHEMBL22652 0.75 — —
SCHEMBL8923972 0.75 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004328-A Voriconazole phosphocholine inner salt intermediate, preparation method and method for preparing voriconazole phosphocholine inner salt 重庆西米瑞医药技术有限公司 2021-06-22 — — CN claimed
CN-108627647-B Detection and quantification method of post-translational modification proteomics 四川大学 2020-06-19 — — CN claimed
JP-59141591-A — — None — — JP disclosed
US-20260049309-A1 REGULATION OF ACTIVITY OF RNAI MOLECULES NOVO NORDISK AS (DE) 2026-02-19 — — US disclosed
US-20250122500-A1 RNAi OLIGONUCLEOTIDE CONJUGATES NOVO NORDISK A/S (DK) 2025-04-17 — — US disclosed
WO-2025054459-A1 RNAI OLIGONUCLEOTIDE CONJUGATES DICERNA PHARMACEUTICALS, INC. (US) 2025-03-13 — — WO disclosed
CN-115043874-B Preparation method and application of tri (2-cyanoethyl) phosphite ester 山东海科创新研究院有限公司 2024-11-08 — — CN disclosed
EP-4426432-A1 LIPID CONJUGATION FOR TARGETING OLIGODENDROCYTES OF THE CENTRAL NERVOUS SYSTEM Dicerna Pharmaceuticals, Inc. (US) 2024-09-11 — — EP disclosed
EP-4426839-A1 LIPID CONJUGATION FOR TARGETING ASTROCYTES OF THE CENTRAL NERVOUS SYSTEM Dicerna Pharmaceuticals, Inc. (US) 2024-09-11 — — EP disclosed
US-20240287512-A1 LIPID CONJUGATION FOR TARGETING NEURONS OF THE CENTRAL NERVOUS SYSTEM NOVO NORDISK A/S (DK) 2024-08-29 — — US disclosed
CN-118271360-A Fluorinated phosphate, preparation method thereof, nonaqueous electrolyte containing fluorinated phosphate and electrochemical device 深圳市研一新材料有限责任公司 2024-07-02 — — CN disclosed
EP-4021915-A1 LIGAND-2'-MODIFIED NUCLEIC ACIDS, SYNTHESIS THEREOF AND INTERMEDIATE COMPOUNDS THEREOF Dicerna Pharmaceuticals, Inc. (US) 2022-07-06 — — EP disclosed
WO-2021146488-A1 4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2021-07-22 — — WO disclosed
CN-113004328-A Voriconazole phosphocholine inner salt intermediate, preparation method and method for preparing voriconazole phosphocholine inner salt 重庆西米瑞医药技术有限公司 2021-06-22 — — CN disclosed
WO-2021041756-A1 LIGAND-2'-MODIFIED NUCLEIC ACIDS, SYNTHESIS THEREOF AND INTERMEDIATE COMPOUNDS THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2021-03-04 — — WO disclosed
US-20080119645-A1 Immobilization; solid phase synthesis ISIS PHARMACEUTICALS, INC. (US) 2008-05-22 — — US disclosed
WO-2005108411-A2 SUBSTITUTED PIXYL PROTECTING GROUPS FOR OLIGONUCLEOTIDE SYNTHESIS ISIS PHARMACEUTICALS, INC. (US) 2005-11-17 — — WO disclosed
EP-1165575-A1 PHOSPHATE CONTAINING MACROCYCLIC IMMUNOMODULATORS ABBOTT LABORATORIES (US) 2002-01-02 — — EP disclosed
WO-2000058318-A1 PHOSPHATE CONTAINING MACROCYCLIC IMMUNOMODULATORS ABBOTT LABORATORIES (US) 2000-10-05 — — WO disclosed
JP-S59141591-A PREPARATION OF AMMONIUM (5-IODO-3-INDOLYL) 5'-THYMIDYLATE FUJIREBIO INC 1984-08-14 — — JP disclosed
Send feedback